NDC 60429-502 is a in the category. It is labeled and distributed by .
Proprietary Name | NDC 60429-502 |
Marketing Category | / |
Marketing Category | ANDA |
Application Number | ANDA074174 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-03-28 |
Marketing End Date | 2017-10-10 |
Marketing Category | ANDA |
Application Number | ANDA074174 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-03-28 |
Marketing End Date | 2017-10-10 |
Marketing Category | ANDA |
Application Number | ANDA074174 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-03-28 |
Marketing End Date | 2017-10-10 |
Marketing Category | ANDA |
Application Number | ANDA074174 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-03-28 |
Marketing End Date | 2017-10-10 |
Marketing Category | ANDA |
Application Number | ANDA074174 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-03-28 |
Marketing End Date | 2017-10-10 |
Marketing Category | ANDA |
Application Number | ANDA074174 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-03-28 |
Marketing End Date | 2017-10-10 |
Marketing Category | ANDA |
Application Number | ANDA074174 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-03-28 |
Marketing End Date | 2017-10-10 |
Marketing Category | ANDA |
Application Number | ANDA074174 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-03-28 |
Marketing End Date | 2017-10-10 |
Marketing Category | ANDA |
Application Number | ANDA074174 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-03-28 |
Marketing End Date | 2017-10-10 |